The medications (semaglutide, tirzepatide, liraglutide, etc.) are GLP-1 receptor agonists . "Agonist" means they bind to and activate the same receptors as natural GLP-1. The difference is that they have been chemically modified to resist degradation by DPP-4, giving them half-lives measured in days rather than minutes.